133.63 USD
↘ 0.37 (0.27%)PRE MARKET (AS OF 04:35 AM EDT)
Gilead Sciences Inc
GILDNASDAQ • USD
Market: OPEN
Open?$133.29
High?$133.73
Low?$133.28
Prev. Close?$133.64
Volume?1.1K
Avg. Volume?5.7M
VWAP?$133.31
Rel. Volume?0.00x
Bid / Ask
Bid?$126.16 × 100
Ask?$141.21 × 100
Spread?$15.05
Midpoint?$133.69
Valuation & Ratios
Market Cap?165.4B
Shares Out?1.2B
Float?1.2B
Float %?99.7%
P/E Ratio?19.44
P/B Ratio?7.29
EPS?$6.86
Dividend?2.42%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?1.55Adequate
Quick Ratio?1.40Adequate
Cash Ratio?0.64Adequate
Debt/Equity?1.10Moderate
ValuationFAIRLY VALUED
Score67/100
P/E?19.4FAIR▾
P/B?7.29FAIR▾
P/S?5.62FAIR▾
P/FCF?17.5CHEAP▾
EV/EBITDA?12.7FAIR▾
EV/Sales?6.21HIGH▾
Returns & Efficiency
ROE?37.5%STRONG▾
ROA?14.4%STRONG▾
Cash Flow & Enterprise
FCF?$9.5B
Enterprise Value?$182.8B
Related Companies
News
Profile
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Employees
17.0K
Market Cap
165.4B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1992-01-22
Address
333 LAKESIDE DR
FOSTER CITY, CA 94404
Phone: (650) 574-3000
FOSTER CITY, CA 94404
Phone: (650) 574-3000